In the latest trading session, 26.51 million Purple Biotech Ltd ADR (NASDAQ:PPBT) shares changed hands as the company’s beta touched 1.11. With the company’s most recent per share price at $11.18 changing hands around $7.82 or 233.23% at last look, the market valuation stands at $20.57M. PPBT’s current price is a discount, trading about -107.51% off its 52-week high of $23.20. The share price had its 52-week low at $2.00, which suggests the last value was 82.11% up since then. When we look at Purple Biotech Ltd ADR’s average trading volume, we note the 10-day average is 73640.0 shares, with the 3-month average coming to 49.34K.
Purple Biotech Ltd ADR (NASDAQ:PPBT) trade information
Instantly PPBT is in green as seen in intraday trades today. With action 410.50%, the performance over the past five days has been green. The company’s shares are showing year-to-date downside of -28.33%, with the 5-day performance at 410.50% in the green. However, in the 30-day time frame, Purple Biotech Ltd ADR (NASDAQ:PPBT) is 248.29% up. Looking at the short shares, we see there were 19525.0 shares sold at short interest cover period of 0.43 days.
Purple Biotech Ltd ADR (PPBT) estimates and forecasts
Data shows that the Purple Biotech Ltd ADR share is performing relatively much better than most of its peers within the same industry. As can be gleaned from the statistics, the company’s share value shot -24.46% over the past 6 months, a 95.85% in annual growth rate that is considerably higher than the industry average of 17.70%.
According to analysts, the company will likely register a growth in its current quarter sales, forecast at 0.00%.
Looking at the company’s year-on-year earnings, data shows that the past 5-year has an earnings growth rate of 26.09%. The 2024 estimates are for Purple Biotech Ltd ADR earnings to increase by 95.39%.
PPBT Dividends
Purple Biotech Ltd ADR is expected to release its next quarterly earnings report in January.
Purple Biotech Ltd ADR (NASDAQ:PPBT)’s Major holders
KINGSWOOD WEALTH ADVISORS, LLC holds the second largest percentage of outstanding shares, with 0.8021% or 0.21 million shares worth $84680.0 as of 2024-06-30.
